Mofebutazone
Mofebutazone, a monophenyl analogue of Phenylbutazone (HY-B0230), is an orally active anti-inflammatory agent. Mofebutazone can be used for research of asthma[1][2].
Product Specifications
CAS Number
[2210-63-1]
UNSPSC
12352005
Hazard Statement
H301, H315, H319, H332, H335
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/mofebutazone.html
Purity
98.42
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(C1CCCC)NN(C2=CC=CC=C2)C1=O
Molecular Formula
C13H16N2O2
Molecular Weight
232.28
Precautions
H301, H315, H319, H332, H335
References & Citations
[1]F.T. Delbeke, et al. Determination of mofebutazone and its 4-hydroxy metabolite in plasma and urine by high-performance liquid chromatography. Journal of Chromatography A. Volume 369, 1986, Pages 440-444|[2]Khayyal MT, et al. Tolerability of mofebutazone in asthmatic patients. Int J Clin Pharmacol Res. 1995;15 (4) :145-51.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
040389-ML490 100 µL
PRAMEF20, CT (PRAMEF20, PRAME family member 20/21) (MaxLight 490) discontinued
Ask
View Details 
137883 1 mL
Complement C4 (C4A, Acidic Complement C4, C3 and PZP-like alpha-2-macroglobulin Domain-containing Protein 2, CO4, CPAMD2) (Not for Export EU)
Ask
View Details 
